RMD
HealthcareResmed Inc
Live · NYSE · May 9, Close
What's Moving RMD Today?
No stock-specific AI insight has been generated for RMD yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
RMD News
25 articles- ResMed Inc. stock: Earnings beat but shares slip on guidance concernsAD HOC NEWS·May 9, 2026
- Pay Less, Gain More: RMD, MDT Top Abbott Laboratories StockTrefis·May 9, 2026
- QRG Capital Management Inc. Has $5.39 Million Stock Holdings in ResMed Inc. $RMDMarketBeat·May 7, 2026
- 9 Stocks That Could Defy the ’Sell in May and Go Away’ Trend This TimeInvesting.com·May 5, 2026
- Why ResMed (RMD) Narrative Is Shifting As Analysts Reassess Growth And Valuation AssumptionsYahoo Finance·May 3, 2026
- 2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn DownYahoo Finance·May 2, 2026
- ResMed Q3 Earnings Call HighlightsMarketbeat·May 2, 2026
- RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO AppointmentYahoo Finance·May 2, 2026
- RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins RiseYahoo Finance·May 1, 2026
- ResMed Inc (RMD) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AcquisitionsYahoo Finance·May 1, 2026
- ResMed Inc. Q3 2026 Earnings Call SummaryMoby·May 1, 2026
- ResMed (RMD) Q3 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- ResMed (RMD) Surpasses Q3 Earnings and Revenue EstimatesYahoo Finance·Apr 30, 2026
- ResMed (RMD) Reports Q3 Earnings: What Key Metrics Have to SayYahoo Finance·Apr 30, 2026
- ResMed’s (NYSE:RMD) Q1 CY2026 Sales Beat EstimatesYahoo Finance·Apr 30, 2026
- Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as SuccessorYahoo Finance·Apr 30, 2026
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026Yahoo Finance·Apr 30, 2026
- Did Stronger Profit Forecasts and Sleep Apnea Tailwinds Just Shift ResMed's (RMD) Investment Narrative?Yahoo Finance·Apr 30, 2026
- ResMed Earnings: What To Look For From RMDYahoo Finance·Apr 29, 2026
- Wall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 EarningsYahoo Finance·Apr 29, 2026
- Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and CarefusionGlobeNewswire Inc.·Apr 29, 2026
- These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarYahoo Finance·Apr 27, 2026
- Is It Time To Reassess ResMed (RMD) After Recent Share Price WeaknessYahoo Finance·Apr 25, 2026
- ResMed (RMD) Reports Next Week: Wall Street Expects Earnings GrowthYahoo Finance·Apr 23, 2026
- Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 22, 2026
All 25 articles loaded
Price Data
Fundamentals
Trading
About Resmed Inc
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.